81 related articles for article (PubMed ID: 20950605)
61. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
62. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
[TBL] [Abstract][Full Text] [Related]
63. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
[TBL] [Abstract][Full Text] [Related]
64. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.
Shin HM; Byung Hak Kim ; Eun Yong Chung ; Jung SH; Yeong Shik Kim ; Kyung Rak Min ; Kim Y
Eur J Pharmacol; 2005 Oct; 521(1-3):1-8. PubMed ID: 16183054
[TBL] [Abstract][Full Text] [Related]
65. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells.
Singh S; Bhat MK
Biochem Biophys Res Commun; 2004 May; 318(2):346-53. PubMed ID: 15120608
[TBL] [Abstract][Full Text] [Related]
66. Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseases.
Stohl W
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):351-8. PubMed ID: 17214581
[TBL] [Abstract][Full Text] [Related]
67. Curcumin and autoimmune disease.
Bright JJ
Adv Exp Med Biol; 2007; 595():425-51. PubMed ID: 17569223
[TBL] [Abstract][Full Text] [Related]
68. Curcumin as a Natural Modulator of B Lymphocytes: Evidence from In Vitro and In Vivo Studies.
Mohammadi A; Mashayekhi K; Navashenaq JG; Haftcheshmeh SM
Mini Rev Med Chem; 2022; 22(18):2361-2370. PubMed ID: 35249482
[TBL] [Abstract][Full Text] [Related]
69. Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases.
Rahiman N; Markina YV; Kesharwani P; Johnston TP; Sahebkar A
J Control Release; 2022 Aug; 348():264-286. PubMed ID: 35649486
[TBL] [Abstract][Full Text] [Related]
70. Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB.
Huang G; Yang Y; Xu Z; Zhou P; Gong W; Li Y; Fan J; He F
Eur J Pharmacol; 2011 Jan; 650(1):451-7. PubMed ID: 20950605
[TBL] [Abstract][Full Text] [Related]
71. Immunomodulatory and therapeutic activity of curcumin.
Srivastava RM; Singh S; Dubey SK; Misra K; Khar A
Int Immunopharmacol; 2011 Mar; 11(3):331-41. PubMed ID: 20828642
[TBL] [Abstract][Full Text] [Related]
72. Multiple molecular targets in cancer chemoprevention by curcumin.
Thangapazham RL; Sharma A; Maheshwari RK
AAPS J; 2006 Jul; 8(3):E443-9. PubMed ID: 17025261
[TBL] [Abstract][Full Text] [Related]
73. Targeting Nuclear Factor-Kappa B Signaling Pathway by Curcumin: Implications for the Treatment of Multiple Sclerosis.
Gachpazan M; Habbibirad S; Kashani H; Jamialahmadi T; Rahimi HR; Sahebkar A
Adv Exp Med Biol; 2021; 1291():41-53. PubMed ID: 34331683
[TBL] [Abstract][Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
